BOUT vs. FFTY

Last updated Jun 24, 2026

BOUT (Innovator IBD Breakout Opportunities ETF) and FFTY (Innovator IBD 50 ETF) are both exchange-traded funds - BOUT is a Mid Cap Growth Equities fund tracking the IBD Breakout Stocks Total Return Index, while FFTY is a Large Cap Growth Equities fund tracking the IBD 50 Index. Both are passively managed. Over the past 5 years, BOUT returned 8.29%/yr vs -0.44%/yr for FFTY. A 0.80 correlation means they provide meaningful diversification when combined. Both charge a 0.80% expense ratio.

Performance

BOUT vs. FFTY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator IBD 50 ETF (FFTY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BOUT achieves a 31.88% return, which is significantly higher than FFTY's 20.94% return.

BOUT

• 1D: -1.91%
• 1M: 3.56%
• YTD: 31.88%
• 6M: 28.55%
• 1Y: 34.68%
• 3Y*: 16.89%
• 5Y*: 8.29%
• 10Y*: —

FFTY

• 1D: -4.21%
• 1M: 5.39%
• YTD: 20.94%
• 6M: 18.21%
• 1Y: 36.43%
• 3Y*: 21.26%
• 5Y*: -0.44%
• 10Y*: 7.91%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BOUT vs. FFTY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
BOUT Innovator IBD Breakout Opportunities ETF	31.88%	-6.77%	18.82%	13.27%	-22.60%	22.69%	50.56%	20.59%	-30.42%
FFTY Innovator IBD 50 ETF	20.94%	23.38%	18.36%	12.40%	-51.08%	11.92%	18.20%	25.74%	-26.91%

Correlation

The correlation between BOUT and FFTY is 0.80, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.80
Correlation (3Y) Calculated over the trailing 3-year period	0.80
Correlation (5Y) Calculated over the trailing 5-year period	0.79
Correlation (All Time) Calculated using the full available price history since Sep 13, 2018	0.80

The correlation between BOUT and FFTY has been stable across timeframes, ranging from 0.79 to 0.80 - a consistent structural relationship.

BOUT vs. FFTY - Sectors Allocation Comparison

Sectors	BOUT	FFTY
Technology	33.0%	39.4%
Financial Services	18.3%	6.7%
Basic Materials	12.3%	2.9%
Consumer Cyclical	10.8%	2.3%
Utilities	7.0%	2.1%
Healthcare	6.5%	12.8%
Consumer Defensive	4.8%	2.8%
Energy	4.0%	7.3%
Real Estate	3.9%	-
Communication Services	3.3%	2.8%
Industrials	3.2%	23.1%

Return for Risk

BOUT vs. FFTY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOUT

BOUT Risk / Return Rank: 51
BOUT Sharpe Ratio Rank: 49
BOUT Sortino Ratio Rank: 45
BOUT Omega Ratio Rank: 45
BOUT Calmar Ratio Rank: 64
BOUT Martin Ratio Rank: 54

FFTY

FFTY Risk / Return Rank: 30
FFTY Sharpe Ratio Rank: 29
FFTY Sortino Ratio Rank: 27
FFTY Omega Ratio Rank: 29
FFTY Calmar Ratio Rank: 33
FFTY Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOUT vs. FFTY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator IBD 50 ETF (FFTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BOUT	FFTY	Difference
Sharpe ratio: Return per unit of total volatility	1.59	1.02	+0.57
Sortino ratio: Return per unit of downside risk	2.17	1.44	+0.73
Omega ratio: Gain probability vs. loss probability	1.28	1.19	+0.09
Calmar ratio: Return relative to maximum drawdown	2.96	1.57	+1.39
Martin ratio: Return relative to average drawdown	8.76	4.14	+4.62

BOUT vs. FFTY - Sharpe Ratio Comparison

The current BOUT Sharpe Ratio is 1.59, which is higher than the FFTY Sharpe Ratio of 1.02. The chart below compares the historical Sharpe Ratios of BOUT and FFTY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BOUT vs. FFTY - Drawdown Comparison

The maximum BOUT drawdown since its inception was -36.98%, smaller than the maximum FFTY drawdown of -59.46%. Use the drawdown chart below to compare losses from any high point for BOUT and FFTY.

Drawdown Indicators

	BOUT	FFTY	Difference
Max Drawdown Largest peak-to-trough decline	-36.98%	-59.46%	+22.48%
Max Drawdown (1Y) Largest decline over 1 year	-11.76%	-23.29%	+11.53%
Max Drawdown (3Y) Largest decline over 3 years	-25.31%	-29.60%	+4.29%
Max Drawdown (5Y) Largest decline over 5 years	-28.28%	-59.46%	+31.18%
Max Drawdown (10Y) Largest decline over 10 years	—	-59.46%	—
Current Drawdown Current decline from peak	-1.91%	-14.76%	+12.85%
Average Drawdown Average peak-to-trough decline	-12.29%	-22.34%	+10.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.97%	8.82%	-4.85%

Volatility

BOUT vs. FFTY - Volatility Comparison

The current volatility for Innovator IBD Breakout Opportunities ETF (BOUT) is 8.27%, while Innovator IBD 50 ETF (FFTY) has a volatility of 13.44%. This indicates that BOUT experiences smaller price fluctuations and is considered to be less risky than FFTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BOUT	FFTY	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.27%	13.44%	-5.17%
Volatility (6M) Calculated over the trailing 6-month period	17.22%	28.50%	-11.28%
Volatility (1Y) Calculated over the trailing 1-year period	21.92%	35.99%	-14.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.71%	29.63%	-9.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.00%	27.67%	-4.67%

BOUT vs. FFTY - Expense Ratio Comparison

Both BOUT and FFTY have an expense ratio of 0.80%.

Dividends

BOUT vs. FFTY - Dividend Comparison

BOUT's dividend yield for the trailing twelve months is around 0.26%, less than FFTY's 1.11% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BOUT Innovator IBD Breakout Opportunities ETF	0.26%	0.34%	0.60%	1.32%	1.35%	0.00%	0.00%	0.00%	0.22%	0.00%
FFTY Innovator IBD 50 ETF	1.11%	1.35%	0.91%	0.65%	2.75%	0.22%	0.00%	0.00%	0.00%	0.17%

Frequently Asked Questions

Can I hold both BOUT and FFTY in my portfolio?

BOUT and FFTY have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BOUT or FFTY?

FFTY has higher volatility (13.44%) compared to BOUT (8.27%). In terms of maximum drawdown, BOUT dropped -36.98% vs FFTY's -59.46%.

Which ETF is better, BOUT or FFTY?

On 5-year performance, BOUT leads with 8.29% vs -0.44% for FFTY. Both ETFs have the same 0.80% expense ratio. On volatility, BOUT has been the lower-risk option at 8.27%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BOUT or FFTY?

Over the 5-year period, BOUT has performed better with a 8.29% return vs -0.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BOUT or FFTY?

BOUT and FFTY have the same expense ratio: 0.80% per year.

Which ETF pays a higher dividend yield, BOUT or FFTY?

FFTY has the higher dividend yield at 1.11%, compared with 0.26% for BOUT.

What is the main difference between BOUT and FFTY?

BOUT is categorized as Mid Cap Growth Equities, while FFTY is Large Cap Growth Equities. BOUT tracks IBD Breakout Stocks Total Return Index, while FFTY tracks IBD 50 Index.

Which has better risk-adjusted returns?

BOUT currently has the higher Sharpe Ratio (1.59 vs 1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.